Long
Ellipsis (EPS) New All-Time Low, What Now? Low Risk/High Rewards
Going low is now as bad as one might think...
Ellipsis (EPSBTC), just hit a new All-Time Low on the second of July.
Today, we can see good volume coming in.
Prices closed above EMA10 yesterday and the bulls are starting to come in.
We have strong bullish divergence with both the MACD and RSI.
This is a good set up...
Low risk with high potential rewards.
Namaste.
Ellipsis (EPSBTC), just hit a new All-Time Low on the second of July.
Today, we can see good volume coming in.
Prices closed above EMA10 yesterday and the bulls are starting to come in.
We have strong bullish divergence with both the MACD and RSI.
This is a good set up...
Low risk with high potential rewards.
Namaste.
Note
Over 80% in growth so far to peak price with potential for more.Enjoy.
🚨 FREE PREMIUM Trades + Top Results
t.me/anandatrades/1183
🚨 FREE Quality Content + New Results
(Frequent Discounts & Offers)
t.me/masteranandatrades/6172
🚨 Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
t.me/anandatrades/1183
🚨 FREE Quality Content + New Results
(Frequent Discounts & Offers)
t.me/masteranandatrades/6172
🚨 Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 FREE PREMIUM Trades + Top Results
t.me/anandatrades/1183
🚨 FREE Quality Content + New Results
(Frequent Discounts & Offers)
t.me/masteranandatrades/6172
🚨 Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
t.me/anandatrades/1183
🚨 FREE Quality Content + New Results
(Frequent Discounts & Offers)
t.me/masteranandatrades/6172
🚨 Go beyond! PREMIUM LIFETIME Access
lamatrades.com (Since 2017)
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.